More about

Inflammatory Bowel Disease

News
May 31, 2022
2 min read
Save

Biologics linked to lower dementia rate in older patients with IBD

SAN DIEGO — Older patients with inflammatory bowel disease who were treated with biologics exhibited a lower incidence of dementia compared with those never treated with biologics, according to data presented at Digestive Disease Week 2022.

News
May 27, 2022
2 min read
Save

Impaired humoral, upheld cellular responses in patients with IBD after SARS-CoV-2 vaccine

SAN DIEGO — Though patients with inflammatory bowel disease have impaired humoral response after SARS-CoV-2 vaccinations, cellular responses were maintained and comparable to those of health care workers, according to study results.

News
May 26, 2022
6 min watch
Save

VIDEO: Tremfya safe, efficacious for moderately to severely active Crohn’s

VIDEO: Tremfya safe, efficacious for moderately to severely active Crohn’s

SAN DIEGO — In this video exclusive, Remo Panaccione, MD, of the University of Calgary, discussed a study assessing the safety and efficacy of Tremfya in patients with moderately to severely active Crohn’s disease.

News
May 24, 2022
3 min read
Save

Interactive decision aid fails to best standard education for biologic selection in IBD

SAN DIEGO — A novel tool for educating patients with inflammatory bowel disease on biologic therapies failed to improve upon standard education with regard to shared decision-making, according to data presented at Digestive Diseases Week.

News
May 24, 2022
2 min read
Save

Survey results suggest Black patients face greater barriers to IBD treatment

Survey results suggest Black patients face greater barriers to IBD treatment

SAN DIEGO — Black patients with inflammatory bowel disease were more likely to use older therapies and face continued barriers to effective care, according to survey results presented at Digestive Disease Week 2022.

News
May 24, 2022
2 min read
Save

Why I love rheumatology: It’s all about inter-professionalism

Why I love rheumatology: It’s all about inter-professionalism

This month’s cover story is a roundtable discussing the coordination of care for patients with both ankylosing spondylitis and inflammatory bowel disease, and features commentary from gastroenterologists and rheumatologists, including Miguel Regueiro, MD; Brett Smith, DO; Ashwin N. Ananthakrishnan, MD, MPH, MBBS; Nicole Cotter, MD; Sharon Dudley-Brown, PhD, FNP-BC; and Seyedehsan Navabi, MD. It is a terrific read and reminded me of one of the many reasons that rheumatology is such a terrific specialty — namely, that we have virtually no boundaries.

News
May 24, 2022
12 min read
Save

‘Just pick up the phone’: The case for cross-specialty coordination in AS, IBD

‘Just pick up the phone’: The case for cross-specialty coordination in AS, IBD

Sometimes, the best way to care for a patient is to know one’s own limitations.

News
May 24, 2022
1 min read
Save

Researchers observe no difference between subcutaneous and IV infliximab treatment in IBD

Researchers observe no difference between subcutaneous and IV infliximab treatment in IBD

SAN DIEGO — Subcutaneous infliximab maintained remission among patients with inflammatory bowel disease who switched from IV dosing, according to research presented at Digestive Disease Week.

News
May 23, 2022
2 min read
Save

Early-life dog ownership may protect against development of Crohn’s disease

SAN DIEGO — Dog ownership and close interactions with these pets in early childhood could help prevent later development of Crohn’s disease, according to data presented at Digestive Disease Week 2022.

News
May 16, 2022
2 min read
Save

Antibiotic use linked with an increased risk for older-onset IBD

Antibiotic use linked with an increased risk for older-onset IBD

The use of antibiotics, particularly those targeting gastrointestinal pathogens, was associated with an increased risk for older-onset inflammatory bowel disease, according to a researcher at the Digestive Disease Week 2022 media briefing.

View more